US FDA lays out ambitious goals for driving drug and device innovation, but funding hazy
This article was originally published in Clinica
Executive Summary
The US Food and Drug Administration has developed a set of actions it plans to take to buoy drug and device innovation by creating a rapid drug development pathway for targeted therapies, streamlining and reforming regulations and beefing up the agency's outreach to small businesses.